Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation
Authors
Keywords
-
Journal
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2019-08-23
DOI
10.1080/10837450.2019.1659818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies
- (2019) Dnyandev G. Gadhave et al. AAPS PHARMSCITECH
- Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies
- (2019) Dnyandev G. Gadhave et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Intranasal teriflunomide microemulsion: An improved chemotherapeutic approach in glioblastoma
- (2019) Dnyandev Gadhave et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
- (2018) Alessandro Giuliani et al. DRUG DELIVERY
- Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery
- (2018) Luigi Battaglia et al. Expert Opinion on Drug Delivery
- A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers
- (2018) Satish K. Mandlik et al. Drug Delivery and Translational Research
- Neutropenia and leukopenia protective intranasal olanzapine-loaded lipid-based nanocarriers engineered for brain delivery
- (2018) Dnyandev Gadhave et al. Applied Nanoscience
- Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity
- (2017) Hira Choudhury et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting
- (2017) Aarti Belgamwar et al. Artificial Cells Nanomedicine and Biotechnology
- Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability
- (2017) Shweta Gupta et al. Biomed Research International
- Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
- (2016) Anam Khan et al. MOLECULAR PHARMACEUTICS
- Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity
- (2016) Luc Bertrand et al. Scientific Reports
- Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid
- (2015) Rajshree L. Shinde et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Optimization of nanostructured lipid carriers of lamotrigine for brain delivery:in vitrocharacterization andin vivoefficacy in epilepsy
- (2014) Tausif Alam et al. Expert Opinion on Drug Delivery
- Donepezil nanosuspension intended for nose to brain targeting: In vitro and in vivo safety evaluation
- (2014) Bhavna et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Quantitative analysis of drug delivery to the brain via nasal route
- (2014) Luba Kozlovskaya et al. JOURNAL OF CONTROLLED RELEASE
- Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route
- (2014) Rudree Pathak et al. Acta Pharmaceutica Sinica B
- Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model
- (2012) Shadab Md et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa
- (2012) Swati Pund et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat
- (2011) Roxana N. Peroni et al. BIOCHEMICAL PHARMACOLOGY
- Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1
- (2010) R. Corbau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex vivo and in vivo characterization
- (2010) Ramesh Gannu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting anti-HIV drugs to the CNS
- (2009) Kavitha S Rao et al. Expert Opinion on Drug Delivery
- Nanoparticles for direct nose-to-brain delivery of drugs
- (2009) Alpesh Mistry et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting
- (2008) Xiaomei Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting
- (2008) Mukesh Kumar et al. JOURNAL OF DRUG TARGETING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now